Evidence map›Paper›PMID 31734117›Full record

ArticleJournal of vascular surgery2020

Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.

Takegawa Yoshida, Kim-Lien Nguyen, Puja Shahrouki, William J Quinones-Baldrich, Peter F Lawrence, J Paul Finn

Open access · greenAbstract read
In one paragraph

Article in Journal of vascular surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Ferumoxytol-enhanced cardiovascular magnetic resonance imaging: applications and technical advances.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Takegawa YoshidaDiagnostic Cardiovascular Imaging Laboratory, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif.
Kim-Lien NguyenDiagnostic Cardiovascular Imaging Laboratory, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif; Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, Calif.
Puja ShahroukiDiagnostic Cardiovascular Imaging Laboratory, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif.
William J Quinones-BaldrichDepartment of Vascular Surgery, David Geffen School of Medicine at UCLA, Los Angeles, Calif.
Peter F LawrenceDepartment of Vascular Surgery, David Geffen School of Medicine at UCLA, Los Angeles, Calif.
J Paul FinnDiagnostic Cardiovascular Imaging Laboratory, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif. Electronic address: pfinn@mednet.ucla.edu.
University of California, Los Angeles · USUCLA Health · US

Funding

Ferumoxytol-Enhanced Cardiac MRI for Ischemic Heart DiseaseR01HL148182 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NGUYEN, KIM-LIEN T · 2020 to 2024
$3.8M
Tailoring Stress Cardiac MRI for Women with Ischemic Heart DiseaseI01CX001901 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI NGUYEN, KIM-LIEN T · 2019 to 2025
–
American Heart Association-American Stroke Association 18TPA34170049CSRD VA I01 CX001901NHLBI NIH HHS R01 HL148182
6 · The paper itself

Abstract

objectiveThe purpose of this study was to establish the feasibility of fusing complementary, high-contrast features from unenhanced computed tomography (CT) and ferumoxytol-enhanced magnetic resonance angiography (FE-MRA) for preprocedural vascular mapping in patients with renal impairment.

methodsIn this Institutional Review Board-approved and Health Insurance Portability and Accountability Act-compliant study, 15 consecutive patients underwent both FE-MRA and unenhanced CT scanning, and the complementary high-contrast features from both modalities were fused to form an integrated, multifeature image. Source images from CT and MRA were segmented and registered. To validate the accuracy, precision, and concordance of fused images to source images, unambiguous landmarks, such as wires from implantable medical devices or indwelling catheters, were marked on three-dimensional (3D) models of the respective modalities, followed by rigid co-registration, interactive fusion, and fine adjustment. We then compared the positional offsets using pacing wires or catheters in the source FE-MRA (defined as points of interest [POIs]) and fused images (n = 5 patients, n = 247 points). Points within 3D image space were referenced to the respective modalities: x (right-left), y (anterior-posterior), and z (cranial-caudal). The respective 3D orthogonal reference axes from both image sets were aligned, such that with perfect registration, a given point would have the same (x, y, z) component values in both sets. The 3D offsets (Δx mm, Δy mm, Δz mm) for each of the corresponding POIs represent nonconcordance between the source FE-MRA and fused images. The offsets were compared using concordance correlation coefficients. Interobserver agreement was assessed using intraclass correlation coefficients and Bland-Altman analyses.

resultsThirteen patients (aged 76 ± 12 years; seven female) with aortic valve stenosis and chronic kidney disease and two patients with thoracoabdominal vascular aneurysms and chronic kidney disease underwent FE-MRA for preprocedural vascular assessment, and unenhanced CT examinations were available in all patients. No ferumoxytol-related adverse events occurred. There were 247 matched POIs evaluated on the source FE-MRA and fused images. In patients with implantable medical devices, the mean offsets in spatial position were 0.31 ± 0.51 mm (ρ = 0.99; C

conclusionsAccurate 3D feature fusion is feasible, combining luminal information from FE-MRA with vessel wall information on unenhanced CT. This framework holds promise for combining the complementary strengths of magnetic resonance imaging and CT to generate information-rich, multifeature composite vascular images while avoiding the respective risks and limitations of both modalities.

Indexed as

AgedFemaleFerrosoferric OxideHumansImage Processing, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance AngiographyMaleProstheses and ImplantsRenal InsufficiencyTomography, X-Ray ComputedVascular DiseasesFerrosoferric OxideComputed tomographyEndovascularFerumoxytolImage fusionIntermodalityMagnetic resonance angiographyTranscatheterVascular mapping

Identifiers

PMID31734117
PMCPMC9583800
OpenAlexW2984389260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.